Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 9 » default
Diabetes, Metabolic Syndrome and Obesity
ISSN: 1178-7007
- View all (2643)
- Volume 17, 2024 (198)
- Volume 16, 2023 (373)
- Volume 15, 2022 (350)
- Volume 14, 2021 (449)
- Volume 13, 2020 (486)
- Volume 12, 2019 (269)
- Volume 11, 2018 (92)
- Volume 10, 2017 (52)
- Volume 9, 2016 (45)
- Volume 8, 2015 (59)
- Volume 7, 2014 (61)
- Volume 6, 2013 (50)
- Volume 5, 2012 (41)
- Volume 4, 2011 (46)
- Volume 3, 2010 (45)
- Volume 2, 2009 (22)
- Volume 1, 2008 (5)
Archive: Volume 9, 2016
Acarbose promotes remission of both early and late dumping syndromes in post-bariatric patients
Cadegiani FA, Silva OS
Diabetes, Metabolic Syndrome and Obesity 2016, 9:443-446
Published Date: 7 December 2016
rDNA insulin glargine U300 – a critical appraisal
Wang F, Zassman S, Goldberg PA
Diabetes, Metabolic Syndrome and Obesity 2016, 9:425-441
Published Date: 2 December 2016
Evaluation of serum ferritin and some metal elements in type 2 diabetes mellitus patients: comparative cross-sectional study
Wolide AD, Zawdie B, Alemayehu T, Tadesse S
Diabetes, Metabolic Syndrome and Obesity 2016, 9:417-424
Published Date: 2 December 2016
Symptom profiles of subsyndromal depression in disease clusters of diabetes, excess weight, and progressive cerebrovascular conditions: a promising new type of finding from a reliable innovation to estimate exhaustively specified multiple indicators–multiple causes (MIMIC) models
Francoeur RB
Diabetes, Metabolic Syndrome and Obesity 2016, 9:391-416
Published Date: 8 December 2016
eHealth technologies to support nutrition and physical activity behaviors in diabetes self-management
Rollo ME, Aguiar EJ, Williams RL, Wynne K, Kriss M, Callister R, Collins CE
Diabetes, Metabolic Syndrome and Obesity 2016, 9:381-390
Published Date: 4 November 2016
Trends in medication use in patients with type 2 diabetes mellitus: a long-term view of real-world treatment between 2000 and 2015
Higgins V, Piercy J, Roughley A, Milligan G, Leith A, Siddall J, Benford M
Diabetes, Metabolic Syndrome and Obesity 2016, 9:371-380
Published Date: 1 November 2016
Practical combination therapy based on pathophysiology of type 2 diabetes
Levin PA
Diabetes, Metabolic Syndrome and Obesity 2016, 9:355-369
Published Date: 31 October 2016
Teneligliptin real-world efficacy assessment of type 2 diabetes mellitus patients in India (TREAT-INDIA study)
Ghosh S, Trivedi S, Sanyal D, Modi KD, Kharb S
Diabetes, Metabolic Syndrome and Obesity 2016, 9:347-353
Published Date: 8 November 2016
Changes in HbA1c, body weight, and systolic blood pressure in type 2 diabetes patients initiating dapagliflozin therapy: a primary care database study
Scheerer MF, Rist R, Proske O, Meng A, Kostev K
Diabetes, Metabolic Syndrome and Obesity 2016, 9:337-345
Published Date: 31 October 2016
Myocutaneous revascularization following graded ischemia in lean and obese mice
Clark RM, Coffman B, McGuire PG, Howdieshell TR
Diabetes, Metabolic Syndrome and Obesity 2016, 9:325-336
Published Date: 30 September 2016
Exercise portrayal in children’s television programs: analysis of the UK and Irish programming
Scully P, Reid O, Macken AP, Healy M, Saunders J, Leddin D, Cullen W, Dunne CP, O’Gorman CS
Diabetes, Metabolic Syndrome and Obesity 2016, 9:317-324
Published Date: 23 September 2016
Management of pancreatogenic diabetes: challenges and solutions
Makuc J
Diabetes, Metabolic Syndrome and Obesity 2016, 9:311-315
Published Date: 25 August 2016
Role of sleep quality in the metabolic syndrome
Koren D, Dumin M, Gozal D
Diabetes, Metabolic Syndrome and Obesity 2016, 9:281-310
Published Date: 25 August 2016
Prevalence and determinants of metabolic syndrome: a cross-sectional survey of general medical outpatient clinics using National Cholesterol Education Program-Adult Treatment Panel III criteria in Botswana
Omech B, Tshikuka JG, Mwita JC, Tsima B, Nkomazana O, Amone-P'Olak K
Diabetes, Metabolic Syndrome and Obesity 2016, 9:273-279
Published Date: 30 August 2016
Natural dipeptidyl peptidase-IV inhibitor mangiferin mitigates diabetes- and metabolic syndrome-induced changes in experimental rats
Suman RK, Mohanty IR, Maheshwari U, Borde MK, Deshmukh YA
Diabetes, Metabolic Syndrome and Obesity 2016, 9:261-272
Published Date: 29 August 2016
Teneligliptin in management of type 2 diabetes mellitus
Sharma SK, Panneerselvam A, Singh KP, Parmar G, Gadge P, Swami OC
Diabetes, Metabolic Syndrome and Obesity 2016, 9:251-260
Published Date: 16 August 2016
Comparison of efficacy and safety of two starting insulin regimens in non-Asian, Asian Indian, and East Asian patients with type 2 diabetes: a post hoc analysis of the PARADIGM study
Ji L, Min KW, Oliveira J, Lew T, Duan R
Diabetes, Metabolic Syndrome and Obesity 2016, 9:243-249
Published Date: 9 August 2016
Incremental increases in economic burden parallels cardiometabolic risk factors in the US
McQueen RB, Ghushchyan V, Olufade T, Sheehan JJ, Nair KV, Saseen JJ
Diabetes, Metabolic Syndrome and Obesity 2016, 9:233-241
Published Date: 2 August 2016
Effects of vildagliptin relative to sulfonylureas in Muslim patients with type 2 diabetes fasting during Ramadan: influence of age and treatment with/without metformin in the VIRTUE study
Hassoun AAK, Pathan MF, Medlej RC, Alarouj M, Shaltout I, Chawla MS, Knap D, Vaz JA
Diabetes, Metabolic Syndrome and Obesity 2016, 9:225-232
Published Date: 26 July 2016
Real-world glycemic outcomes in patients with type 2 diabetes initiating exenatide once weekly and liraglutide once daily: a retrospective cohort study
Saunders WB, Nguyen H, Kalsekar I
Diabetes, Metabolic Syndrome and Obesity 2016, 9:217-223
Published Date: 15 July 2016
Smartphone applications to aid weight loss and management: current perspectives
Sutton EF, Redman LM
Diabetes, Metabolic Syndrome and Obesity 2016, 9:213-216
Published Date: 18 July 2016
The relationship between the presence of lower urinary tract symptoms and waist circumference
Oliveira MC, Varella LR, Angelo PH, Micussi MT
Diabetes, Metabolic Syndrome and Obesity 2016, 9:207-211
Published Date: 11 July 2016
Adherence to GLP-1 receptor agonist therapy administered by once-daily or once-weekly injection in patients with type 2 diabetes in Germany
Qiao Q, Ouwens MJNM, Grandy S, Johnsson K, Kostev K
Diabetes, Metabolic Syndrome and Obesity 2016, 9:201-205
Published Date: 28 June 2016
Fatty acid desaturase 1 knockout mice are lean with improved glycemic control and decreased development of atheromatous plaque
Powell DR, Gay JP, Smith M, Wilganowski N, Harris A, Holland A, Reyes M, Kirkham L, Kirkpatrick LL, Zambrowicz B, Hansen G, Platt KA, van Sligtenhorst I, Ding ZM, Desai U
Diabetes, Metabolic Syndrome and Obesity 2016, 9:185-199
Published Date: 22 June 2016
Assessing the incremental benefit of an extended duration lifestyle intervention for the components of the metabolic syndrome
Walden P, Jiang Q, Jackson EA, Oral EA, Weintraub MS, Rubenfire M
Diabetes, Metabolic Syndrome and Obesity 2016, 9:177-184
Published Date: 1 June 2016
A qualitative study of perceptions of determinants of disease burden among young patients with type 1 diabetes and their parents in South India
Verloo H, Meenakumari M, Abraham EJ, Malarvizhi G
Diabetes, Metabolic Syndrome and Obesity 2016, 9:169-176
Published Date: 19 May 2016
An indirect comparison of HbA1c treatment effect with albiglutide and exenatide 2.0 mg QW using the Bucher method
Martin AA, Parks D
Diabetes, Metabolic Syndrome and Obesity 2016, 9:163-168
Published Date: 19 May 2016
Depression in diabetic patients attending University of Gondar Hospital Diabetic Clinic, Northwest Ethiopia
Birhanu AM, Alemu FM, Ashenafie TD, Balcha SA, Dachew BA
Diabetes, Metabolic Syndrome and Obesity 2016, 9:155-162
Published Date: 11 May 2016
Sources and implications of NADH/NAD+ redox imbalance in diabetes and its complications
Wu J, Jin Z, Zheng H, Yan LJ
Diabetes, Metabolic Syndrome and Obesity 2016, 9:145-153
Published Date: 10 May 2016
Metabolic syndrome and C-reactive protein in bank employees
Cattafesta M, Bissoli NS, Salaroli LB
Diabetes, Metabolic Syndrome and Obesity 2016, 9:137-144
Published Date: 10 May 2016
Advances in the treatment of type 2 diabetes: impact of dulaglutide
Thompson AM, Trujillo JM
Diabetes, Metabolic Syndrome and Obesity 2016, 9:125-136
Published Date: 4 May 2016
Level of control among patients with type 2 diabetes mellitus attending diabetic clinic under family medicine compared to diabetic clinic under endocrinology
AlHabdan MA, AlAteeq MA, AlJurbou FI
Diabetes, Metabolic Syndrome and Obesity 2016, 9:119-124
Published Date: 18 April 2016
Prescription omega-3 fatty acid products: considerations for patients with diabetes mellitus
Tajuddin N, Shaikh A, Hassan A
Diabetes, Metabolic Syndrome and Obesity 2016, 9:109-118
Published Date: 19 April 2016
Lifestyle Intervention for Weight Loss: a group-based program for Emiratis in Ajman, United Arab Emirates
Sadiya A, Abdi S, Abusnana S
Diabetes, Metabolic Syndrome and Obesity 2016, 9:101-108
Published Date: 18 March 2016
Hematological indices and their correlation with fasting blood glucose level and anthropometric measurements in type 2 diabetes mellitus patients in Gondar, Northwest Ethiopia
Biadgo B, Melku M, Abebe SM, Abebe M
Diabetes, Metabolic Syndrome and Obesity 2016, 9:91-99
Published Date: 17 March 2016
Childhood obesity: prevention is better than cure
Pandita A, Sharma D, Pandita D, Pawar S, Tariq M, Kaul A
Diabetes, Metabolic Syndrome and Obesity 2016, 9:83-89
Published Date: 15 March 2016
Sodium–glucose cotransporter-2 inhibitor combination therapy to optimize glycemic control and tolerability in patients with type 2 diabetes: focus on dapagliflozin–metformin
Schwartz SS, Katz A
Diabetes, Metabolic Syndrome and Obesity 2016, 9:71-82
Published Date: 15 March 2016
Genistein treatment increases bone mass in obese, hyperglycemic mice
Michelin RM, Al-Nakkash L, Broderick TL, Plochocki JH
Diabetes, Metabolic Syndrome and Obesity 2016, 9:63-70
Published Date: 15 March 2016
Effects of long-term exercise training on adipose tissue expression of fractalkine and MCP-1 in patients with type 2 diabetes and stable coronary artery disease: a substudy of a randomized controlled trial
Njerve IU, Byrkjeland R, Arnesen H, Åkra S, Solheim S, Seljeflot I
Diabetes, Metabolic Syndrome and Obesity 2016, 9:55-62
Published Date: 14 March 2016
Metabolic syndrome and associated factors among outpatients of Jimma University Teaching Hospital
Abda E, Hamza L, Tessema F, Cheneke W
Diabetes, Metabolic Syndrome and Obesity 2016, 9:47-53
Published Date: 4 March 2016
Long-term weight loss maintenance for obesity: a multidisciplinary approach
Montesi L, El Ghoch M, Brodosi L, Calugi S, Marchesini G, Dalle Grave R
Diabetes, Metabolic Syndrome and Obesity 2016, 9:37-46
Published Date: 26 February 2016
Patient considerations in type 2 diabetes – role of combination dapagliflozin–metformin XR
Kuecker CM, Vivian EM
Diabetes, Metabolic Syndrome and Obesity 2016, 9:25-35
Published Date: 23 February 2016
Fracture risk in patients with type 2 diabetes under different antidiabetic treatment regimens: a retrospective database analysis in primary care
Pscherer S, Kostev K, Dippel FW, Rathmann W
Diabetes, Metabolic Syndrome and Obesity 2016, 9:17-23
Published Date: 19 February 2016
Assessment of vitamin D levels in newly diagnosed children with type 1 diabetes mellitus comparing two methods of measurement: a facility's experience in the Middle Eastern country of Bahrain
Al-Haddad FA, Rajab MH, Al-Qallaf SM, Musaiger AO, Hart KH
Diabetes, Metabolic Syndrome and Obesity 2016, 9:11-16
Published Date: 25 January 2016
A local renal renin–angiotensin system activation via renal uptake of prorenin and angiotensinogen in diabetic rats
Tojo A, Kinugasa S, Fujita T, Wilcox CS
Diabetes, Metabolic Syndrome and Obesity 2016, 9:1-10
Published Date: 18 January 2016